Consequences of high-dose steroid therapy for acute spinal cord injury.
about
Methylprednisolone in the management of spinal cord injuries: Lessons from randomized, controlled trialsBiomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord.Continuous brain-derived neurotrophic factor (BDNF) infusion after methylprednisolone treatment in severe spinal cord injury."A surviving myth"--corticosteroids are still considered ulcerogenic by a majority of physicians.Non-surgical management of spinal cord injury.Methylprednisolone for acute spinal cord injury: not a standard of careNanomedicine for treating spinal cord injury.Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Systematic Review and Meta-Analysis.Caspase inhibitors as neuroprotective agents.Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord.Evaluation of the Combination of Methylprednisolone and Tranilast after Spinal Cord Injury in Rat Models.Nanoparticle-mediated local delivery of Methylprednisolone after spinal cord injuryCombined Transplantation of Human Neuronal and Mesenchymal Stem Cells following Spinal Cord InjuryMortality and morbidity after high-dose methylprednisolone treatment in patients with acute cervical spinal cord injury: a propensity-matched analysis using a nationwide administrative database.A review: the role of high dose methylprednisolone in spinal cord trauma in children.Emergency neurological life support: traumatic spine injury.Pharmacological therapy for acute spinal cord injury.Methylprednisolone for the treatment of acute spinal cord injury: point.From demyelination to remyelination: the road toward therapies for spinal cord injury.Emergency Neurological Life Support: Traumatic Spine Injury.Analysis of prehospital care and emergency room treatment of patients with acute traumatic spinal cord injury: a retrospective cohort study on the implementation of current guidelines.Journal Club: Long-term functional outcome in patients with acquired infections after acute spinal cord injury.Peroxisome proliferator-activated receptor-γ agonist rosiglitazone reduces secondary damage in experimental spinal cord injury.Clinical trials in spinal cord injury: lessons learned on the path to translation. The 2011 International Spinal Cord Society Sir Ludwig Guttmann Lecture.Coadministration of methylprednisolone with hypertonic saline solution improves overall neurological function and survival rates in a chronic model of spinal cord injury.Cyclosporine-A-mediated inhibition of p-glycoprotein increases methylprednisolone entry into the central nervous system.Effect of postinjury intravenous or intrathecal methylprednisolone on spinal cord excitatory amino-acid release, nitric oxide generation, PGE2 synthesis, and myeloperoxidase content in a pig model of acute spinal cord injury.High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients.Multifunctional nanoparticles for gene delivery and spinal cord injury.Pharmacological Therapy after Acute Cervical Spinal Cord Injury.Emergency Neurological Life Support: Traumatic Spine Injury.Localized delivery of methylprednisolone sodium succinate with polymeric nanoparticles in experimental injured spinal cord model.Carvedilol promotes neurological function, reduces bone loss and attenuates cell damage after acute spinal cord injury in rats.Treatment of a Spinal Cord Hemitransection Injury with Keratin Biomaterial Hydrogel Elicits Recovery and Tissue Repair
P2860
Q26782453-ECC18EB8-93D7-4E20-9EC5-A0A72133B1FBQ33653678-9E767208-A4F2-4090-AD3C-3CD7D73E6643Q33654436-2348A5F1-59B4-4156-9E35-EA8869F673A2Q34122092-A238B67C-375C-446F-96EB-3475EAE7E2E5Q34581480-77518042-9C39-4A74-A4B1-2FA3BB6C858DQ34963262-F9C2163B-04CC-484F-AA4D-087A008E3D15Q35216746-2FCDFFD4-CA4F-4C5A-A407-BFC3F9DE2873Q35830572-C772E78B-FECE-4756-BB55-28FFF7AABC3FQ36179653-6F795C11-07FE-4B87-8D9D-966D2440887DQ36633104-B3A69861-6555-45A9-A903-F5E164406945Q37112548-630D8F19-7E10-43C5-8E65-74428802EC1CQ37183229-F9E5BC67-D1EE-43F1-979C-355E8473F2A3Q37371959-BCD6D3D9-7632-4A71-9F6E-BF5755A00822Q37600056-812ACE40-C1EF-46AA-BF87-5CFDF3D856C8Q37945122-07B6E975-7ED2-4FFE-BCFC-9E9AF7D96DF1Q38042354-0F9F6DA6-D5EA-4AC9-8838-77502C8FABBEQ38082348-9A5573C2-34A6-4866-B54B-AC803E3FF145Q38230513-19B24975-6A58-44E1-B8D3-94DB1011DDD0Q38366783-89AABCFB-2B9C-4D2F-B40B-35A360A6E539Q38599753-9EAA1F57-FAA1-49EC-8694-0A90FDEDA6EDQ39724781-01608078-DDEE-42D2-AFCF-9C9149968AB8Q40093330-086CAD3B-CD99-42C3-AC34-4954869B4F1CQ43418201-462125DE-8167-4506-9CDD-FC2AFD61E289Q43863012-32DE4350-0007-495D-8998-849A465BBFB4Q43887880-E8FE0179-9C7E-446B-9C62-663300489D37Q44915490-F052164E-41A8-4A1A-A89F-9D46491E14A5Q44916816-DCE742F7-22EA-4532-94F4-65E079DD71E7Q45144873-E5F45928-ABC0-44F5-873B-A9D898279A0AQ45875230-494A6C23-31C6-4DB3-819D-A21D4D307E69Q49613130-4321207B-4570-44BF-A35D-4A42464601ACQ50075411-48424289-6A7A-43F4-8B42-1B9075699430Q50230512-2A6BEDCE-AC8C-45DC-8542-CAE130886E81Q51032708-2B7AB7C1-0E1F-43D3-A7AA-D1919562CA27Q59048171-6D0C271A-6617-472C-858B-02DEE77277D7
P2860
Consequences of high-dose steroid therapy for acute spinal cord injury.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Consequences of high-dose steroid therapy for acute spinal cord injury.
@en
type
label
Consequences of high-dose steroid therapy for acute spinal cord injury.
@en
prefLabel
Consequences of high-dose steroid therapy for acute spinal cord injury.
@en
P2093
P1433
P1476
Consequences of high-dose steroid therapy for acute spinal cord injury.
@en
P2093
Micheals AJ
Papadopoulos SM
Rodriguez JL
P304
P356
10.1097/00005373-199702000-00017
P407
P577
1997-02-01T00:00:00Z